IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 228 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $115,656 | -3.3% | 18,929 | +1.1% | 0.01% | -12.5% |
| Q4 2022 | $119,627 | -30.0% | 18,721 | +4.9% | 0.01% | -27.3% |
| Q3 2022 | $171,000 | -36.7% | 17,842 | +10.2% | 0.01% | -21.4% |
| Q1 2022 | $270,000 | +8.0% | 16,190 | +23.6% | 0.01% | -6.7% |
| Q4 2021 | $250,000 | -64.7% | 13,101 | -14.2% | 0.02% | -70.6% |
| Q4 2020 | $708,000 | +17.0% | 15,264 | -16.9% | 0.05% | +155.0% |
| Q3 2020 | $605,000 | – | 18,365 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 2,222,701 | $25,005,000 | 8.92% |
| Broadfin Capital, LLC | 4,894,361 | $55,062,000 | 8.10% |
| GREAT POINT PARTNERS LLC | 3,496,340 | $39,334,000 | 6.13% |
| FRAZIER MANAGEMENT LLC | 2,188,331 | $24,619,000 | 4.51% |
| Prosight Management, LP | 715,317 | $8,047,000 | 4.49% |
| Avoro Capital Advisors LLC | 8,662,720 | $97,456,000 | 4.48% |
| QVT Financial LP | 821,361 | $8,748,000 | 2.26% |
| Perceptive Advisors | 7,290,199 | $82,014,000 | 2.19% |
| Rhenman & Partners Asset Management AB | 1,290,495 | $14,518,000 | 1.46% |
| EMORY UNIVERSITY | 185,915 | $2,092,000 | 1.37% |